Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITEDHEALTH GROUP INCUNH · Entity 2809 | Acting General Counsel | April 17, 2007 | April 20, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITEDHEALTH GROUP INC
Report date April 17, 2007 · Filed April 20, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.87 · Expires 2015-01-04 | Direct | 0 |
Reported balance
After 2007-04-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2007-04-17 · Disposition to issuer · Disposed 90,000 · Balance 0 F1: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.92 · Expires 2015-01-04 | Direct | 90,000 |
Reported balance
After 2007-04-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2007-04-17 · Grant · Acquired 90,000 · Balance 90,000 F1: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.34 · Expires 2015-05-02 | Direct | 0 |
Reported balance
After 2007-04-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2007-04-17 · Disposition to issuer · Disposed 30,000 · Balance 0 F1: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.57 · Expires 2015-05-02 | Direct | 30,000 |
Reported balance
After 2007-04-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2007-04-17 · Grant · Acquired 30,000 · Balance 30,000 F1: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.89 · Expires 2015-10-31 | Direct | 0 |
Reported balance
After 2007-04-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2007-04-17 · Disposition to issuer · Disposed 20,000 · Balance 0 F1: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.07 · Expires 2015-10-31 | Direct | 20,000 |
Reported balance
After 2007-04-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2007-04-17 · Grant · Acquired 20,000 · Balance 20,000 F1: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2007 Filed Apr 20, 2007 01:25 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $60.07 | Not disclosed |
DisclosureSEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 6 Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2015-10-31 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:25 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $57.89 | Not disclosed |
DisclosureSEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 5 Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2015-10-31 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:25 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $48.57 | Not disclosed |
DisclosureSEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 4 Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2015-05-02 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:25 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $47.34 | Not disclosed |
DisclosureSEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 3 Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2015-05-02 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:25 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 90,000 | Not disclosed Strike: $47.92 | Not disclosed |
DisclosureSEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 2 Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2015-01-04 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
| April 17, 2007 Filed Apr 20, 2007 01:25 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 90,000 | Not disclosed Strike: $42.87 | Not disclosed |
DisclosureSEC source: 0001181431-07-026258 · rrd155058.xml · derivative · entry 1 Burke Forrest Gregory · CIK 0001379886 · Acting General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2015-01-04 F1 · date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · kind: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · price: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. F1 · derivative.exercise_date: Reflects action taken to increase the exercise price of any stock option (or portion thereof) that was granted to Mr. Burke prior to his becoming an executive officer of UnitedHealth Group Incorporated and is potentially subject to a surtax under Section 409A of the Internal Revenue Code to the closing price of the Company's common stock on the accounting measurement date for that stock option. For Section 16 reporting purposes only, the increases in option exercise prices are deemed to be a cancellation of the old options and the grant of replacement options. The other terms of the outstanding options (including the vesting of the options) remain unchanged. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.